NEWS IN BRIEF...
Honeywell said it plans to spin-off its Advanced Materials business into an independent, US publicly traded company.
www.honeywell.com
Röhm has granted Albis additional distribution rights for Plexiglas and Plex- imid moulding compounds in the Scandinavian regions, as well as the Baltic states. Previously, this cooperation covered markets in Turkey and North Africa.
www.roehm.com
www.albis.com
Neste and Braskem have announced an agreement on the supply of renewable and recycled feedstocks for polymers and chemicals production, with Braskem products based on these feedstocks expected to be available from the fourth quarter of 2024.
www.neste.com
www.braskem.com.br
Evonik Oxeno to expand PVC plasticisers capacity
Evonik Oxeno, the C4 chemicals arm of Germany’s Evonik group, has an- nounced it is “significantly expanding” its production capacities for isononanol- based PVC plasticisers. The company did not
provide details of the new capacities for the INA-based plasticisers, Elatur CH (DINCH) and Elatur DINCD. The capacity expansions will be integrated into the existing network of C4 plants in Marl, Germany. “The capacity expansion
marks another important milestone in the diversifica- tion of our plasticiser portfolio,” said Frank Beiss- mann, MD of Evonik Oxeno. “To meet the growing demand for these products, we will begin work this year.” n Evonik said it is reorganis- ing core offerings in its
Evonik’s facility in Marl, Germany
Coating & Adhesive Resins and Health Care business units and selling off non- core businesses which contribute sales of €350m. Coating & Adhesive
Resins will now focus on two areas: liquid polybutadienes as additives for adhesives and sealants or tyres, and specialty acrylics for medical technology and the packag- ing industry. The business
unit’s polyolefins business, with sales of around €100m, will be transferred to Evonik’s C4 chain business. In March, Evonik an- nounced it would cut up to 2,000 jobs, the majority in Germany, by the end of 2026 as part of a €400m restructuring and cost cutting programme dubbed ‘Evonik Tailor Made.’ �
www.evonik.com
Americhem to sell ColorRx in Europe
Americhem Healthcare said it is introducing its ColorRx compounds and master- batch in a variety of stand- ard colours and base resins to the European market. “We’re furthering our
‘global reach, regional focus’ by extending Amer- ichem’s capabilities to meet increasing European healthcare industry demand for high quality polymer materials,” said Barto DuPlessis, Vice President and General Manager, Europe. “Our masterbatch and compounding excel-
6 COMPOUNDING WORLD | November 2024
lence for advanced surgical instrumentation, robotic- assisted surgery, drug delivery, catheters, hearing aids and more lines up perfectly with the needs of
the European healthcare market.” ColorRx polymers will be
produced in one of three ISO 13485 and cGMP compliant global facilities,
ensuring the highest standards of quality and reliability, it said. The formulations under-
go rigorous biocompatibility testing, providing peace of mind for healthcare applica- tions. The company also offers formulations that are RoHS and REACH compliant ensuring that medical devices can be used worldwide, meeting international standards and regulations. Custom colour matching is also part of the offering. �
www.americhem.com
www.compoundingworld.com
IMAGE: AMERICHEM
IMAGE: EVONIK
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
